Cargando…

Immune Checkpoint Inhibitor-Induced Hemophagocytic Lymphohistiocytosis in a Patient With Squamous Cell Carcinoma

Programmed cell death protein 1 (PD-1) checkpoint inhibitors such as pembrolizumab are novel therapeutics used to treat various advanced malignancies and have been shown to increase patient survival in several studies. However, these drugs have a toxicity profile that ranges from mild side effects s...

Descripción completa

Detalles Bibliográficos
Autores principales: Marar, Rosalyn, Prathivadhi-Bhayankaram, Sruti, Krishnan, Mridula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451547/
https://www.ncbi.nlm.nih.gov/pubmed/36118548
http://dx.doi.org/10.14740/jh1033